Overview
Updated 14 Jul 2026
Uma Borate, MD, is Associate Professor, Division of Hematology (also cited as Clinical Associate Professor / Acute Leukemia Clinical Research Director) at The Ohio State University (Division of Hematology / OSUCCC – James, James Cancer Hospital and Solove Research Institute), Columbus, OH. The public record shows 293 publications with 7,956 citations (h-index 33), centered on Hematology. It also documents an investigator role on 11 registered clinical trials, industry payments reported by 26 companies.
- Most recent indexed publication: 2026 · Blood advances
- Top research focus: Hematology
- 11 registered trials on ClinicalTrials.gov
- Open Payments reporting from 26 companies
Generated from the cited public record · current as of 14 Jul 2026. Every fact links its source below.
Indications focusfrom trials led + research topics
Research focusOpenAlex concept fingerprint
Drugs & moleculesacross trials, industry payments and publications
Works withtrial sponsors and companies reporting payments
Scholarshipindexed output and impact (OpenAlex)
View publications ↓Distinct works indexed by OpenAlex, matched via ORCID; 11 in PubMed.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industrytrials, payments and federal funding
Federally funded research awards.
Clinical trials
Updated 14 Jul 2026
Listed as an investigator on 11 registered studies on ClinicalTrials.gov. The most recent:
- Comparing Different Treatment Lengths for Venetoclax in Older People With Newly Diagnosed Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial)
Sponsor: National Cancer Institute (NCI)
InvestigatorPhase 2Not, yet, recruitingNCT07437950 - Ziftomenib for the Treatment of Patients With NPM1 Mutated or KMT2A Rearranged Acute Myeloid Leukemia Not Eligible for Standard Therapy
Sponsor: Uma Borate
InvestigatorPhase 2Not, yet, recruitingNCT06930352 - Evaluate the Safety, Tolerability, Pharmacokinetic Profile, Efficacy of Bl-M11D1
Sponsor: SystImmune Inc.
InvestigatorPhase 1RecruitingNCT06714591
Industry payments
Updated 14 Jul 2026
26 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Daiichi Sankyo Inc.Program year202512 payments$10,610openpaymentsdata.cms.gov ↗
- Syndax Pharmaceuticals, Inc.Program year202511 payments
- Incyte CorporationProgram year202512 payments
NIH funding
We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →
Publications
Updated 14 Jul 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
Contact
No public contact details on file. This person's NPPES record doesn't include a practice address or telephone number. Why? →
Background & recognition
Updated 14 Jul 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Educationdegrees and training on record
- MBBS (medical degree)
B.J. Medical College, University of Pune
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →health.usnews.com ↗ - M.S.
Pathobiology and Molecular Medicine, University of Cincinnati
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →aamds.org ↗ - Residency
Albert Einstein Medical Center, Philadelphia
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →health.usnews.com ↗ - Fellowship in Hematology/Oncology
University of Alabama
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →aamds.org ↗
Editorial & leadership rolesjournal and society appointments
- Disease Group Leader
MDS and MPN Clinical Trial Disease Groups, OSUCCC – James Leukemia Research Program
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →aamds.org ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →aamds.org ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →aamds.org ↗
Awards & honorshonors on the public record
- Evans MDS Discovery Research Grant recipient (2022)
for project on targeting the inflammasome in high-risk clonal cytopenia patients to prevent progression to MDS/AML
2022verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →evansmds.org ↗
Secondary affiliationsappointments beyond the home institution
- Formerly Oregon Health & Science University (OHSU)
Portland, OR, prior institutional affiliation before move to Ohio State
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →patientpower.info ↗ - Member: Southwest Oncology Group (SWOG)
American Society of Hematology (ASH), American Society of Clinical Oncology (ASCO), American Association for Cancer Research (AACR)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →runx1-fpd.org ↗
Media & interviewspress, podcasts and appearances
- "Treatments for MDS and Secondary AML"
video interview with Uma Borate and Jacqueline Garcia, YouTube
2025provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com ↗ - provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →oncbrothers.com ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →patientpower.info ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Online presence
Updated 14 Jul 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accountspublic accounts run by this person
- X / Twitter
x.com/beatalleukemia
Mentions by otherswhere others cite or feature them
- X / Twitter
x.com/OhioStateWIMS/status/1541930176963133440
- YouTube
youtube.com/watch
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com ↗ - X / Twitter
X/Twitter handle @beatalleukemia, bio: "Dr. Uma Borate: Associate Professor"
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →x.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
William Carson, MD
The Ohio State University
- 687
- publications
- 76
- h-index
- 16
- trials
Kathleen Dungan, MD
The Ohio State University
- 252
- publications
- 34
- h-index
- 9
- trials